Price Alert

Immunovant Inc. (IMVT)

NASDAQ: IMVT · Real-Time Price · USD

15.17

-0.03 (-0.20%)

At close: Aug 15, 2025, 3:59 PM

15.22

0.33%

After-hours: Aug 15, 2025, 06:46 PM EDT

Immunovant Cash Flow Statement

Financials in USD. Fiscal year is April - March.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Net Income	-413.84M	-259.34M	-210.96M	-156.73M	-107.43M
Depreciation & Amortization	377K	231K	193K	126K	65K
Stock-Based Compensation	49.49M	41.12M	32.3M	34.24M	18.82M
Other Working Capital	-25.69M	1.41M	5.36M	10.52M	3.31M
Other Non-Cash Items	133K	1.13M	1.13M	1.11M	933K
Deferred Income Tax	n/a	n/a	n/a	n/a	-282K
Change in Working Capital	-12.03M	2.63M	-10.85M	15.14M	4.57M
Operating Cash Flow	-375.87M	-214.23M	-188.19M	-106.11M	-83.33M
Capital Expenditures	-759K	-360K	-197K	-254K	-210K
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	n/a	n/a	n/a	n/a
Investing Cash Flow	-759K	-360K	-197K	-254K	-210K
Debt Repayment	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	n/a	n/a	385K	200.13M	383.11M
Financial Cash Flow	454.49M	472.43M	70.89M	200.13M	383.11M
Net Cash Flow	78.61M	258.83M	-117.28M	93.67M	299.57M
Free Cash Flow	-376.63M	-214.59M	-188.39M	-106.37M	-83.54M